RERAX
Price
$52.49
Change
+$0.35 (+0.67%)
Updated
Apr 25 closing price
Net Assets
124.55B
TIGAX
Price
$22.95
Change
+$0.06 (+0.26%)
Updated
Apr 25 closing price
Net Assets
692.68M
Ad is loading...

RERAX vs TIGAX

Header iconRERAX vs TIGAX Comparison
Open Charts RERAX vs TIGAXBanner chart's image
American Funds Europacific Growth R1
Price$52.49
Change+$0.35 (+0.67%)
VolumeN/A
Net Assets124.55B
Thornburg International Growth A
Price$22.95
Change+$0.06 (+0.26%)
VolumeN/A
Net Assets692.68M
RERAX vs TIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERAX vs. TIGAX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and TIGAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 125B vs. TIGAX (693M). RERAX pays higher dividends than TIGAX: RERAX (0.46) vs TIGAX (0.03). RERAX was incepted earlier than TIGAX: RERAX (23 years) vs TIGAX (18 years). RERAX (1.57) is less costly to investors than TIGAX (1.38). TIGAX is a more actively managed with annual turnover of: 63.54 vs. RERAX (30.00). RERAX has a lower initial minimum investment than TIGAX: RERAX (250) vs TIGAX (5000). RERAX annual gain was more profitable for investors over the last year : -1.86 vs. TIGAX (-9.08). RERAX return over 5 years is better than : 23.31 vs. TIGAX (5.98).
RERAXTIGAXRERAX / TIGAX
Total Expense Ratio1.571.38114%
Annual Report Gross Expense Ratio1.571.38114%
Fund Existence23 years18 years-
Gain YTD4.0850.791517%
Front LoadN/A5%-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets125B693M18,038%
Annual Yield % from dividends0.460.031,810%
Returns for 1 year-1.86-9.0820%
Returns for 3 years8.756.07144%
Returns for 5 years23.315.98390%
Returns for 10 years7.2115.7346%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COIIX17.11N/A
N/A
Calvert International Opportunities I
RYOIX62.20N/A
N/A
Rydex Biotechnology Inv
MPEGX20.94N/A
N/A
Morgan Stanley Inst Discovery I
TSCHX16.33N/A
N/A
Nuveen Quant Small Cap Equity I
TRZBX172.21N/A
N/A
T. Rowe Price Blue Chip Growth Z